| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 106.099 | 76 |
| GSM780708 | Untreated after 4 days (C2_1) | 91.156 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 100.39 | 75 |
| GSM780719 | Untreated after 4 days (C1_2) | 100.018 | 75 |
| GSM780720 | Untreated after 4 days (C2_2) | 92.0137 | 74 |
| GSM780721 | Untreated after 4 days (C3_2) | 95.9522 | 75 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 111.906 | 77 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 93.3382 | 74 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 106.41 | 76 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 103.574 | 76 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 97.0916 | 75 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 109.141 | 76 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 98.5491 | 75 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 94.2568 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 104.088 | 76 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 93.7696 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 115.613 | 77 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 101.497 | 75 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 110.902 | 77 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 112.908 | 77 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 80.628 | 72 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 94.0897 | 74 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 103.089 | 76 |